PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
07-May-2020 New study reveals blueprint for getting out of Covid-19 lockdown University of East Anglia
07-May-2020 Scientists bring together world’s coronavirus research in 'intelligent' online database The Institute of Cancer Research
07-May-2020 Sosei Heptares announces further scientific progress with orexin agonist program in conjunction with spin-off companies Orexia and Inexia Sosei Heptares
07-May-2020 PTC Therapeutics to Acquire Censa Pharmaceuticals PTC Therapeutics
07-May-2020 MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements MediPharm Labs
07-May-2020 Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients Evelo Biosciences, Inc.
07-May-2020 MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements MediPharm Labs
07-May-2020 Bone Therapeutics raises additional EUR 4.0 million, totalling EUR 15 million, providing runway into Q2 2021 Bone Therapeutics
06-May-2020 SCOTTISH LIFE SCIENCE COMPANY DEVELOPS COVID-19 ANTIBODY SCREENING TRIALS TO AID QUEST FOR VACCINE DEVELOPMENT Arrayjet Limited
06-May-2020 Santhera Signs Agreements in Gene Therapy Research for Congenital Muscular Dystrophy with Rutgers University Santhera Pharmaceuticals
06-May-2020 Antabio Receives QIDP Designation from the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO’s Priority Pathogens Antabio SAS
06-May-2020 Trio of Awards for Synergy Vision in Just One (Four-Day-Working) Week … prestigious Platinum from Investors in People, UK’s 3rd Best Small Workplace for 2020 by Great Place to Work® and platinum and gold Muse Creative Awards … Synergy Vision (SV)
05-May-2020 Richmond Research Institute partnering to ensure faster COVID-19 point of care testing and longer-term immunity studies Richmond Research Institute
05-May-2020 Stilla Technologies offers a digital PCR solution to detect Covid-19 infections more sensitively and more accurately than the current RT-PCR method Stilla Technologies
05-May-2020 CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of Head and Neck Cancer CEL-SCI Corporation
05-May-2020 Biomaterial immune control discoveries could reduce implant rejection The University of Nottingham
05-May-2020 Vaxxel acquires Transgene's DuckCelt®-T17 cell line to develop industrial-scale vaccines against respiratory viruses Vaxxel SAS
05-May-2020 Freeline receives Orphan Drug Designation from the FDA for FLT190 for the treatment of Fabry Disease Freeline
05-May-2020 Sensyne Health announces launch of new BPm-Health™ free-of-charge across NHS in response to COVID-19 pandemic Sensyne Health
05-May-2020 Vifor Pharma announces Akebia’s Positive top-line results from global phase-III program of vadadustat for treatment of anaemia due to Chronic Kidney Disease in adult dialysis-dependent patients Vifor Pharma